Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -2.7% Market Closed
Market Cap: 190.4m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Relative Value

ALA doesn't have a meaningful market cap.

The Relative Value of one ALA stock under the Base Case scenario is 0.001 AUD. Compared to the current market price of 0.18 AUD, Arovella Therapeutics Ltd is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALA Relative Value
Base Case
0.001 AUD
Overvaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
1
Median 3Y
171.6
Median 5Y
71.1
Industry
2.5
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-5.7
Industry
21.9
Forward
-17.7
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-8.2
Industry
16.5
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-8.2
Industry
23.6
vs History
14
vs Industry
1
Median 3Y
8.2
Median 5Y
3.1
Industry
2.1
vs History
1
vs Industry
0
Median 3Y
159.7
Median 5Y
47.2
Industry
2.6
vs History
6
vs Industry
0
Median 3Y
188.5
Median 5Y
81.7
Industry
5.2
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-4.9
Industry
13.3
Forward
-15.1
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-4.9
Industry
16.6
Forward
-16.9
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-7.4
Industry
15.6
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-6.6
Industry
19.1
vs History
vs Industry
3
Median 3Y
4.3
Median 5Y
1.6
Industry
1.9

Multiples Across Competitors

ALA Competitors Multiples
Arovella Therapeutics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Arovella Therapeutics Ltd
ASX:ALA
189.1m AUD 1 214.2 -21.6 -20.2 -20.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.7B USD 18.3 89.6 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.8 24.2 27.6
US
Johnson & Johnson
NYSE:JNJ
372B USD 4.2 25.3 12.2 15.9
US
Merck & Co Inc
NYSE:MRK
257.3B USD 4.1 21.2 10.7 12.8
CH
Roche Holding AG
SIX:ROG
200.6B CHF 3.4 17.4 9.8 11.7
UK
AstraZeneca PLC
LSE:AZN
162.5B GBP 4.2 31.7 169.5 254
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.1 11.5 10 13.9
US
Pfizer Inc
NYSE:PFE
146B USD 2.4 34.3 10.3 15.6
P/E Multiple
Earnings Growth
AU
Arovella Therapeutics Ltd
ASX:ALA
Average P/E: 33.2
Negative Multiple: -21.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.6
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.8
86%
US
Johnson & Johnson
NYSE:JNJ
25.3
-22%
US
Merck & Co Inc
NYSE:MRK
21.2
7 321%
CH
Roche Holding AG
SIX:ROG
17.4
32%
UK
AstraZeneca PLC
LSE:AZN
31.7
177%
CH
Novartis AG
SIX:NOVN
11.5
21%
US
Pfizer Inc
NYSE:PFE
34.3
733%

See Also

Discover More
Back to Top